

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 9.96198773 |
| 2 | epithelial cilium movement (GO:0003351) | 9.29554453 |
| 3 | primary alcohol catabolic process (GO:0034310) | 8.61254258 |
| 4 | ethanol metabolic process (GO:0006067) | 7.86114170 |
| 5 | axoneme assembly (GO:0035082) | 6.99924148 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.87838925 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.87838925 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 6.78686680 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.78686680 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 6.65758034 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.41613054 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.41613054 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.41613054 |
| 14 | left/right pattern formation (GO:0060972) | 6.24808338 |
| 15 | lysine metabolic process (GO:0006553) | 6.12407227 |
| 16 | lysine catabolic process (GO:0006554) | 6.12407227 |
| 17 | vitamin transmembrane transport (GO:0035461) | 6.07245618 |
| 18 | kynurenine metabolic process (GO:0070189) | 6.06487437 |
| 19 | glyoxylate metabolic process (GO:0046487) | 6.03743933 |
| 20 | tryptophan metabolic process (GO:0006568) | 6.01709430 |
| 21 | diterpenoid biosynthetic process (GO:0016102) | 6.01393975 |
| 22 | epoxygenase P450 pathway (GO:0019373) | 5.61579842 |
| 23 | cysteine metabolic process (GO:0006534) | 5.52489960 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.39583472 |
| 25 | urate metabolic process (GO:0046415) | 5.28387762 |
| 26 | regulation of cilium movement (GO:0003352) | 5.21972155 |
| 27 | drug catabolic process (GO:0042737) | 5.12549561 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.12047428 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.11671280 |
| 30 | drug transmembrane transport (GO:0006855) | 5.10651091 |
| 31 | homocysteine metabolic process (GO:0050667) | 5.08714479 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.08497069 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.92615986 |
| 34 | urea cycle (GO:0000050) | 4.90039057 |
| 35 | urea metabolic process (GO:0019627) | 4.90039057 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 4.86811002 |
| 37 | retinoic acid metabolic process (GO:0042573) | 4.86506314 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.81407952 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.81161967 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.78094377 |
| 41 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.77355745 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.75459695 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.75459695 |
| 44 | left/right axis specification (GO:0070986) | 4.74432928 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 4.70556201 |
| 46 | primary alcohol metabolic process (GO:0034308) | 4.64878167 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 4.63923095 |
| 48 | benzene-containing compound metabolic process (GO:0042537) | 4.62536872 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 4.60206172 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.55011588 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 4.53040093 |
| 52 | heme transport (GO:0015886) | 4.51376962 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.50897618 |
| 54 | bile acid metabolic process (GO:0008206) | 4.49186966 |
| 55 | protein carboxylation (GO:0018214) | 4.43235630 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43235630 |
| 57 | drug transport (GO:0015893) | 4.38145599 |
| 58 | progesterone metabolic process (GO:0042448) | 4.37090866 |
| 59 | exogenous drug catabolic process (GO:0042738) | 4.36061387 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 4.35424808 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 4.34417557 |
| 62 | amine catabolic process (GO:0009310) | 4.34257447 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.34257447 |
| 64 | regulation of fibrinolysis (GO:0051917) | 4.31989764 |
| 65 | retinol metabolic process (GO:0042572) | 4.31079030 |
| 66 | phospholipid efflux (GO:0033700) | 4.30769760 |
| 67 | glutamate metabolic process (GO:0006536) | 4.26626907 |
| 68 | microtubule bundle formation (GO:0001578) | 4.26059510 |
| 69 | terpenoid biosynthetic process (GO:0016114) | 4.26011841 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.25750877 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 4.25346247 |
| 72 | tyrosine metabolic process (GO:0006570) | 4.23085326 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.20064234 |
| 74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.17947256 |
| 75 | ventricular system development (GO:0021591) | 4.17674193 |
| 76 | regulation of protein activation cascade (GO:2000257) | 4.17527886 |
| 77 | cellular glucuronidation (GO:0052695) | 4.15530341 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 4.11549214 |
| 79 | complement activation, alternative pathway (GO:0006957) | 4.09491228 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08750231 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 4.08750231 |
| 82 | macromolecular complex remodeling (GO:0034367) | 4.08750231 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 4.07842053 |
| 84 | intraciliary transport (GO:0042073) | 4.04928830 |
| 85 | response to mercury ion (GO:0046689) | 4.04632287 |
| 86 | one-carbon compound transport (GO:0019755) | 4.03416197 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 4.02291493 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 4.02161240 |
| 89 | ethanol oxidation (GO:0006069) | 4.01772637 |
| 90 | negative regulation of humoral immune response (GO:0002921) | 4.01400828 |
| 91 | lung epithelium development (GO:0060428) | 4.00824153 |
| 92 | glycine metabolic process (GO:0006544) | 3.89963370 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.87987775 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.87987775 |
| 95 | regulation of complement activation (GO:0030449) | 3.87117422 |
| 96 | reverse cholesterol transport (GO:0043691) | 3.84896717 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 3.84391662 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.83729150 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.83385299 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 3.83237839 |
| 101 | cilium organization (GO:0044782) | 3.82618565 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.80747812 |
| 103 | negative regulation of B cell mediated immunity (GO:0002713) | 3.80703193 |
| 104 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.80703193 |
| 105 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80109623 |
| 106 | response to nitrosative stress (GO:0051409) | 3.80041098 |
| 107 | establishment of apical/basal cell polarity (GO:0035089) | 3.78696371 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.78237533 |
| 109 | organic acid catabolic process (GO:0016054) | 3.78237533 |
| 110 | sperm capacitation (GO:0048240) | 3.77709341 |
| 111 | L-ascorbic acid metabolic process (GO:0019852) | 3.77329260 |
| 112 | xenobiotic catabolic process (GO:0042178) | 3.76642096 |
| 113 | fatty acid oxidation (GO:0019395) | 3.76312271 |
| 114 | response to xenobiotic stimulus (GO:0009410) | 3.75753556 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73972680 |
| 116 | fatty acid beta-oxidation (GO:0006635) | 3.72434132 |
| 117 | drug metabolic process (GO:0017144) | 3.72022684 |
| 118 | carnitine metabolic process (GO:0009437) | 3.70667297 |
| 119 | coenzyme catabolic process (GO:0009109) | 3.70613854 |
| 120 | cilium assembly (GO:0042384) | 3.70325299 |
| 121 | acylglycerol homeostasis (GO:0055090) | 3.69810499 |
| 122 | triglyceride homeostasis (GO:0070328) | 3.69810499 |
| 123 | phosphate ion transport (GO:0006817) | 3.69106139 |
| 124 | lipid oxidation (GO:0034440) | 3.68810339 |
| 125 | protein-lipid complex assembly (GO:0065005) | 3.68786781 |
| 126 | valine metabolic process (GO:0006573) | 3.68179302 |
| 127 | ketone body metabolic process (GO:1902224) | 3.62437025 |
| 128 | negative regulation of lipase activity (GO:0060192) | 3.61952341 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 3.60881323 |
| 130 | tolerance induction (GO:0002507) | 3.58962675 |
| 131 | cholesterol efflux (GO:0033344) | 3.58483609 |
| 132 | arginine metabolic process (GO:0006525) | 3.56679234 |
| 133 | phosphate ion transmembrane transport (GO:0035435) | 3.55331143 |
| 134 | monocarboxylic acid catabolic process (GO:0072329) | 3.55123385 |
| 135 | bile acid and bile salt transport (GO:0015721) | 3.53175126 |
| 136 | fibrinolysis (GO:0042730) | 3.49848598 |
| 137 | C21-steroid hormone metabolic process (GO:0008207) | 3.45458291 |
| 138 | intestinal cholesterol absorption (GO:0030299) | 3.45136151 |
| 139 | polyketide metabolic process (GO:0030638) | 3.43545981 |
| 140 | doxorubicin metabolic process (GO:0044598) | 3.43545981 |
| 141 | daunorubicin metabolic process (GO:0044597) | 3.43545981 |
| 142 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.35338960 |
| 143 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.26059029 |
| 144 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.24945474 |
| 145 | glomerular epithelial cell development (GO:0072310) | 3.22898674 |
| 146 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.20327211 |
| 147 | establishment of monopolar cell polarity (GO:0061162) | 3.17627879 |
| 148 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.17627879 |
| 149 | phenylpropanoid metabolic process (GO:0009698) | 3.16959309 |
| 150 | cellular aldehyde metabolic process (GO:0006081) | 3.16947918 |
| 151 | protein localization to cilium (GO:0061512) | 3.16313492 |
| 152 | centriole assembly (GO:0098534) | 3.16292385 |
| 153 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.16073782 |
| 154 | retinal metabolic process (GO:0042574) | 3.09671619 |
| 155 | hydrogen peroxide catabolic process (GO:0042744) | 3.09572930 |
| 156 | sodium ion homeostasis (GO:0055078) | 3.05815673 |
| 157 | regulation of interleukin-5 production (GO:0032674) | 3.04127375 |
| 158 | regulation of microtubule-based movement (GO:0060632) | 2.99844934 |
| 159 | * xenobiotic metabolic process (GO:0006805) | 2.98334859 |
| 160 | axonemal dynein complex assembly (GO:0070286) | 15.2591843 |
| 161 | cilium or flagellum-dependent cell motility (GO:0001539) | 12.5404828 |
| 162 | cilium movement (GO:0003341) | 10.7454902 |
| 163 | motile cilium assembly (GO:0044458) | 10.1370925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.79468058 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.74676859 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.30298358 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.07569164 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.40286361 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71954268 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52756766 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83077078 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.64038193 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30651355 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29811835 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29291729 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.18429134 |
| 14 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.16559932 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14923369 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03248509 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9439583 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93730659 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57945018 |
| 20 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.55176301 |
| 21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49077286 |
| 22 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.46321271 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44785343 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44532285 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44383999 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42744418 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42516563 |
| 28 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.37054751 |
| 29 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36327367 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31508006 |
| 31 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.31421074 |
| 32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.30521744 |
| 33 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.29987996 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29733796 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29514472 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29511997 |
| 37 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.29330081 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27301850 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25751094 |
| 40 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21434214 |
| 41 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.20837956 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20757653 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18893090 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18122582 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17103495 |
| 46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.16950474 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16072005 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15523503 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15019112 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12742356 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11839693 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11753872 |
| 53 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11564736 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10985444 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10663267 |
| 56 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09160957 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09123896 |
| 58 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.08737465 |
| 59 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.08445306 |
| 60 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08212180 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06733083 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06630686 |
| 63 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.06083732 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04638333 |
| 65 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.04429218 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03603031 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03068277 |
| 68 | NFYA_21822215_ChIP-Seq_K562_Human | 1.02803335 |
| 69 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.02666252 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02110798 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00890410 |
| 72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99721803 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99311767 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98651313 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97973655 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97207698 |
| 77 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96745646 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96445919 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90977778 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89385065 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89373022 |
| 82 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88386953 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87329877 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86943455 |
| 85 | NFYB_21822215_ChIP-Seq_K562_Human | 0.86929207 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86519520 |
| 87 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85855771 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85450497 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85008828 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84868171 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83657153 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83424160 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83358410 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82601820 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81907433 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80947088 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78784420 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77653876 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77653876 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76578220 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74428721 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74086369 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73342095 |
| 104 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72872742 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72798507 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71067694 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69952312 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69348442 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69210766 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67234281 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66191781 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65888866 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.65828526 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61300640 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61231938 |
| 116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60786705 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58175384 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57700851 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57033882 |
| 120 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56867526 |
| 121 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.56678037 |
| 122 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54367717 |
| 123 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.53075369 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.52720290 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.51379955 |
| 126 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.50724757 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50191770 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50124833 |
| 129 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49786107 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.49343097 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49226731 |
| 132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.48636131 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.48344298 |
| 134 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48012831 |
| 135 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.47679340 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.47439861 |
| 137 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.47102345 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45721715 |
| 139 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.45716570 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45713127 |
| 141 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44312151 |
| 142 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.43779043 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.43779043 |
| 144 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43641483 |
| 145 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42787760 |
| 146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.42764863 |
| 147 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.42718285 |
| 148 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.42542076 |
| 149 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42539099 |
| 150 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.42253581 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42252353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.07403859 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 8.00220392 |
| 3 | MP0005365_abnormal_bile_salt | 5.93503425 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.56774215 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87589112 |
| 6 | MP0002132_abnormal_respiratory_system | 4.31425280 |
| 7 | MP0003195_calcinosis | 3.82920611 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.61185123 |
| 9 | MP0005332_abnormal_amino_acid | 3.59402847 |
| 10 | MP0003252_abnormal_bile_duct | 3.58028191 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 3.19340539 |
| 12 | MP0002653_abnormal_ependyma_morphology | 3.17551493 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.91816257 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.81408791 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.59775743 |
| 16 | MP0009840_abnormal_foam_cell | 2.54112946 |
| 17 | MP0001984_abnormal_olfaction | 2.43191074 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.40655336 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.31957850 |
| 20 | MP0009643_abnormal_urine_homeostasis | 2.28548614 |
| 21 | MP0004133_heterotaxia | 2.25015785 |
| 22 | MP0004043_abnormal_pH_regulation | 2.24978025 |
| 23 | MP0005083_abnormal_biliary_tract | 2.14928543 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.98709093 |
| 25 | MP0005636_abnormal_mineral_homeostasis | 1.93223006 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.85581270 |
| 27 | MP0000609_abnormal_liver_physiology | 1.81173783 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.74738829 |
| 29 | MP0000566_synostosis | 1.67289439 |
| 30 | MP0001764_abnormal_homeostasis | 1.64973627 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57775798 |
| 32 | MP0001756_abnormal_urination | 1.56855238 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 1.54354142 |
| 34 | MP0003186_abnormal_redox_activity | 1.52847488 |
| 35 | MP0005451_abnormal_body_composition | 1.48750279 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.45751964 |
| 37 | MP0002136_abnormal_kidney_physiology | 1.38468989 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.38375858 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.29919427 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.20573586 |
| 41 | MP0003868_abnormal_feces_composition | 1.19594477 |
| 42 | MP0002282_abnormal_trachea_morphology | 1.19279052 |
| 43 | MP0000383_abnormal_hair_follicle | 1.18173303 |
| 44 | MP0001986_abnormal_taste_sensitivity | 1.17737511 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.14833061 |
| 46 | MP0009697_abnormal_copulation | 1.10570860 |
| 47 | MP0002254_reproductive_system_inflammat | 1.08219738 |
| 48 | MP0009764_decreased_sensitivity_to | 1.08005680 |
| 49 | MP0004883_abnormal_blood_vessel | 1.05312231 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.03863855 |
| 51 | MP0003011_delayed_dark_adaptation | 1.02384104 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.00896813 |
| 53 | MP0005164_abnormal_response_to | 0.98413190 |
| 54 | MP0000598_abnormal_liver_morphology | 0.95953856 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 0.95254823 |
| 56 | MP0005408_hypopigmentation | 0.95065491 |
| 57 | MP0005647_abnormal_sex_gland | 0.94104525 |
| 58 | MP0002796_impaired_skin_barrier | 0.93101737 |
| 59 | MP0002160_abnormal_reproductive_system | 0.93042190 |
| 60 | MP0009642_abnormal_blood_homeostasis | 0.90391976 |
| 61 | MP0005670_abnormal_white_adipose | 0.89167808 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.88504430 |
| 63 | MP0000604_amyloidosis | 0.86110495 |
| 64 | MP0005499_abnormal_olfactory_system | 0.86027476 |
| 65 | MP0005394_taste/olfaction_phenotype | 0.86027476 |
| 66 | MP0008469_abnormal_protein_level | 0.85789224 |
| 67 | MP0009763_increased_sensitivity_to | 0.76453871 |
| 68 | MP0005535_abnormal_body_temperature | 0.73647148 |
| 69 | MP0003941_abnormal_skin_development | 0.73613619 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 0.71939240 |
| 71 | MP0005409_darkened_coat_color | 0.71887390 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.71216721 |
| 73 | MP0009053_abnormal_anal_canal | 0.71198472 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.70048578 |
| 75 | MP0003329_amyloid_beta_deposits | 0.69515814 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.68552196 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.68244457 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.67551587 |
| 79 | MP0006082_CNS_inflammation | 0.66452631 |
| 80 | MP0005023_abnormal_wound_healing | 0.65942873 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.65290715 |
| 82 | MP0005248_abnormal_Harderian_gland | 0.65135848 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.64821820 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.64392521 |
| 85 | MP0002168_other_aberrant_phenotype | 0.64074817 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.63873290 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.62942978 |
| 88 | MP0001664_abnormal_digestion | 0.61911875 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.61841712 |
| 90 | MP0002928_abnormal_bile_duct | 0.60971404 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.60722123 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.59077267 |
| 93 | MP0002971_abnormal_brown_adipose | 0.58762041 |
| 94 | MP0001346_abnormal_lacrimal_gland | 0.58017865 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.56578496 |
| 96 | MP0005395_other_phenotype | 0.56373815 |
| 97 | MP0001661_extended_life_span | 0.56371172 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.56236583 |
| 99 | MP0002135_abnormal_kidney_morphology | 0.55924697 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.55230409 |
| 101 | MP0010030_abnormal_orbit_morphology | 0.53232319 |
| 102 | MP0003690_abnormal_glial_cell | 0.53209646 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.52988379 |
| 104 | MP0003303_peritoneal_inflammation | 0.52912428 |
| 105 | MP0002233_abnormal_nose_morphology | 0.52753573 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.52624699 |
| 107 | MP0001270_distended_abdomen | 0.52182689 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.50933849 |
| 109 | MP0000858_altered_metastatic_potential | 0.50886887 |
| 110 | MP0005334_abnormal_fat_pad | 0.48772156 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.46564920 |
| 112 | MP0005266_abnormal_metabolism | 0.46189148 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.45666510 |
| 114 | MP0003879_abnormal_hair_cell | 0.45544562 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.45227511 |
| 116 | MP0001663_abnormal_digestive_system | 0.43364577 |
| 117 | MP0005501_abnormal_skin_physiology | 0.43044672 |
| 118 | MP0003878_abnormal_ear_physiology | 0.41977202 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.41977202 |
| 120 | MP0003953_abnormal_hormone_level | 0.41076542 |
| 121 | MP0008874_decreased_physiological_sensi | 0.40847835 |
| 122 | MP0006035_abnormal_mitochondrial_morpho | 0.40546975 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.39531198 |
| 124 | MP0003075_altered_response_to | 0.39520545 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.38657145 |
| 126 | MP0004885_abnormal_endolymph | 0.37498625 |
| 127 | MP0005166_decreased_susceptibility_to | 0.36808016 |
| 128 | MP0004130_abnormal_muscle_cell | 0.36465213 |
| 129 | MP0008873_increased_physiological_sensi | 0.36326093 |
| 130 | MP0008872_abnormal_physiological_respon | 0.35502555 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.35468308 |
| 132 | MP0003724_increased_susceptibility_to | 0.33594657 |
| 133 | MP0003959_abnormal_lean_body | 0.33527093 |
| 134 | MP0004381_abnormal_hair_follicle | 0.29629320 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.29279066 |
| 136 | MP0005165_increased_susceptibility_to | 0.28337044 |
| 137 | MP0001958_emphysema | 0.28083186 |
| 138 | MP0000639_abnormal_adrenal_gland | 0.27685227 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.26827865 |
| 140 | MP0003718_maternal_effect | 0.26665037 |
| 141 | MP0009115_abnormal_fat_cell | 0.25461495 |
| 142 | MP0001216_abnormal_epidermal_layer | 0.25256262 |
| 143 | MP0009672_abnormal_birth_weight | 0.25252187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal ciliary motility (HP:0012262) | 9.93193198 |
| 2 | Rhinitis (HP:0012384) | 9.74334392 |
| 3 | Chronic bronchitis (HP:0004469) | 7.56926002 |
| 4 | Bronchiectasis (HP:0002110) | 7.02701174 |
| 5 | Nasal polyposis (HP:0100582) | 6.15999874 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.94811615 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 5.59675237 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.59385954 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.36649557 |
| 10 | Xanthomatosis (HP:0000991) | 5.20378919 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.13865075 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 5.08844248 |
| 13 | Hyperglycinuria (HP:0003108) | 5.03821457 |
| 14 | Gout (HP:0001997) | 4.83293717 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.64445531 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.59929892 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.52621164 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.52621164 |
| 19 | Ketosis (HP:0001946) | 4.40580113 |
| 20 | Hyperammonemia (HP:0001987) | 4.35826466 |
| 21 | Hyperglycinemia (HP:0002154) | 4.30225520 |
| 22 | Male infertility (HP:0003251) | 4.13406450 |
| 23 | Recurrent sinusitis (HP:0011108) | 4.11536983 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10835250 |
| 25 | Infertility (HP:0000789) | 4.07207468 |
| 26 | Bronchitis (HP:0012387) | 4.05289184 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 4.03124860 |
| 28 | Hypokalemic alkalosis (HP:0001949) | 3.98776325 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93760937 |
| 30 | Ketoacidosis (HP:0001993) | 3.91353075 |
| 31 | Increased circulating renin level (HP:0000848) | 3.87742826 |
| 32 | Alkalosis (HP:0001948) | 3.84160184 |
| 33 | Complement deficiency (HP:0004431) | 3.83290690 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.79245070 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.73616068 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.70409527 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 3.69864893 |
| 38 | Chronic sinusitis (HP:0011109) | 3.68538053 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.67190645 |
| 40 | Joint hemorrhage (HP:0005261) | 3.64265058 |
| 41 | Metabolic alkalosis (HP:0200114) | 3.62402414 |
| 42 | Hyperuricemia (HP:0002149) | 3.59714687 |
| 43 | Increased purine levels (HP:0004368) | 3.59714687 |
| 44 | Recurrent otitis media (HP:0000403) | 3.56849928 |
| 45 | Proximal tubulopathy (HP:0000114) | 3.54424026 |
| 46 | Fat malabsorption (HP:0002630) | 3.41098844 |
| 47 | Hypolipoproteinemia (HP:0010981) | 3.40958188 |
| 48 | Abnormal urine output (HP:0012590) | 3.39319048 |
| 49 | Polyuria (HP:0000103) | 3.35722042 |
| 50 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31485491 |
| 51 | Occipital encephalocele (HP:0002085) | 3.27638394 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24386637 |
| 53 | Epidermoid cyst (HP:0200040) | 3.24055865 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 3.17660383 |
| 55 | Chronic hepatic failure (HP:0100626) | 3.15780068 |
| 56 | Hypomagnesemia (HP:0002917) | 3.14983147 |
| 57 | Generalized aminoaciduria (HP:0002909) | 3.13292813 |
| 58 | Delayed CNS myelination (HP:0002188) | 3.08883481 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.08280169 |
| 60 | Abnormality of chloride homeostasis (HP:0011422) | 3.06784420 |
| 61 | Abnormality of renal excretion (HP:0011036) | 3.05401635 |
| 62 | Vascular calcification (HP:0004934) | 3.04139564 |
| 63 | Metabolic acidosis (HP:0001942) | 2.90406532 |
| 64 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90071032 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.87074299 |
| 66 | Lethargy (HP:0001254) | 2.84903883 |
| 67 | Chronic otitis media (HP:0000389) | 2.83494197 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.83022714 |
| 69 | Glycosuria (HP:0003076) | 2.78746072 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.78746072 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.77395294 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.75279165 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.75279165 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.74884543 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74884543 |
| 76 | Abnormality of complement system (HP:0005339) | 2.74728093 |
| 77 | Hyperbilirubinemia (HP:0002904) | 2.73803465 |
| 78 | True hermaphroditism (HP:0010459) | 2.73789263 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.70047833 |
| 80 | Malnutrition (HP:0004395) | 2.68326142 |
| 81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67870063 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.67137405 |
| 83 | Steatorrhea (HP:0002570) | 2.64662206 |
| 84 | Atelectasis (HP:0100750) | 2.60670842 |
| 85 | Rickets (HP:0002748) | 2.58951037 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58703629 |
| 87 | Abnormality of magnesium homeostasis (HP:0004921) | 2.57898032 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.57356432 |
| 89 | Vomiting (HP:0002013) | 2.54216572 |
| 90 | Late onset (HP:0003584) | 2.50331494 |
| 91 | Irritability (HP:0000737) | 2.48029670 |
| 92 | Polydipsia (HP:0001959) | 2.45424724 |
| 93 | Abnormal drinking behavior (HP:0030082) | 2.45424724 |
| 94 | Cystic liver disease (HP:0006706) | 2.43578422 |
| 95 | Neonatal onset (HP:0003623) | 2.43453276 |
| 96 | Renal salt wasting (HP:0000127) | 2.41055032 |
| 97 | Spastic diplegia (HP:0001264) | 2.40485853 |
| 98 | Cerebral edema (HP:0002181) | 2.39805694 |
| 99 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36489390 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.31390750 |
| 101 | Hyperaldosteronism (HP:0000859) | 2.28592312 |
| 102 | Enlarged kidneys (HP:0000105) | 2.27756269 |
| 103 | Renal tubular acidosis (HP:0001947) | 2.27346423 |
| 104 | Pancreatic cysts (HP:0001737) | 2.26355625 |
| 105 | Tetany (HP:0001281) | 2.24477614 |
| 106 | Nephrolithiasis (HP:0000787) | 2.24082529 |
| 107 | Molar tooth sign on MRI (HP:0002419) | 2.23741846 |
| 108 | Abnormality of midbrain morphology (HP:0002418) | 2.23741846 |
| 109 | Hyperphosphaturia (HP:0003109) | 2.17905735 |
| 110 | Mitral stenosis (HP:0001718) | 2.16691260 |
| 111 | Spontaneous abortion (HP:0005268) | 2.13155406 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.12896272 |
| 113 | Myocardial infarction (HP:0001658) | 2.08303901 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 2.05985153 |
| 115 | Nephronophthisis (HP:0000090) | 2.02741094 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02589386 |
| 117 | Confusion (HP:0001289) | 2.01712788 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 2.00518913 |
| 119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 11.5668430 |
| 120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.5105502 |
| 121 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.5105502 |
| 122 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.2212505 |
| 123 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.1044183 |
| 124 | Absent/shortened dynein arms (HP:0200106) | 10.1044183 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.98546159 |
| 126 | Decreased circulating renin level (HP:0003351) | 1.98284592 |
| 127 | Pancreatitis (HP:0001733) | 1.97227923 |
| 128 | Nausea (HP:0002018) | 1.94320112 |
| 129 | Postaxial foot polydactyly (HP:0001830) | 1.94030955 |
| 130 | Sensorimotor neuropathy (HP:0007141) | 1.93696305 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93134896 |
| 132 | Tubulointerstitial nephritis (HP:0001970) | 1.88056483 |
| 133 | Male pseudohermaphroditism (HP:0000037) | 1.80431957 |
| 134 | Bell-shaped thorax (HP:0001591) | 1.80124065 |
| 135 | Nephropathy (HP:0000112) | 1.73771989 |
| 136 | Hyperkalemia (HP:0002153) | 1.71858039 |
| 137 | Amyloidosis (HP:0011034) | 1.65859076 |
| 138 | Congenital hepatic fibrosis (HP:0002612) | 1.65805727 |
| 139 | Recurrent bronchitis (HP:0002837) | 1.63538871 |
| 140 | Abnormality of the renal medulla (HP:0100957) | 1.61331518 |
| 141 | Absent frontal sinuses (HP:0002688) | 1.54918255 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 1.47969813 |
| 143 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.45742968 |
| 144 | Anencephaly (HP:0002323) | 1.44002691 |
| 145 | Bifid scrotum (HP:0000048) | 1.43840059 |
| 146 | Oculomotor apraxia (HP:0000657) | 1.42822832 |
| 147 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.41108668 |
| 148 | Asplenia (HP:0001746) | 1.38494716 |
| 149 | Medial flaring of the eyebrow (HP:0010747) | 1.37725763 |
| 150 | Tubular atrophy (HP:0000092) | 1.34626616 |
| 151 | Furrowed tongue (HP:0000221) | 1.34623330 |
| 152 | Glucose intolerance (HP:0000833) | 1.33461064 |
| 153 | Gingival bleeding (HP:0000225) | 1.30978797 |
| 154 | Hyponatremia (HP:0002902) | 1.30866683 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.29957497 |
| 156 | Short thorax (HP:0010306) | 1.26363689 |
| 157 | Osteomalacia (HP:0002749) | 1.25346978 |
| 158 | Flat acetabular roof (HP:0003180) | 1.24832388 |
| 159 | Glomerulonephritis (HP:0000099) | 1.24408026 |
| 160 | Gait imbalance (HP:0002141) | 1.24204340 |
| 161 | Decreased central vision (HP:0007663) | 1.23346124 |
| 162 | Stage 5 chronic kidney disease (HP:0003774) | 1.21786525 |
| 163 | Postaxial hand polydactyly (HP:0001162) | 1.21644599 |
| 164 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.20837010 |
| 165 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.17746650 |
| 166 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.16134935 |
| 167 | Hypotension (HP:0002615) | 1.15932361 |
| 168 | Sclerocornea (HP:0000647) | 1.15534339 |
| 169 | Nephrogenic diabetes insipidus (HP:0009806) | 1.15231855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.85893062 |
| 2 | BCKDK | 5.58920777 |
| 3 | WNK3 | 5.31057105 |
| 4 | OXSR1 | 5.11142043 |
| 5 | FGFR4 | 3.27609819 |
| 6 | MST1R | 3.06512081 |
| 7 | STK39 | 2.88746894 |
| 8 | ERN1 | 2.78681027 |
| 9 | SIK1 | 2.50438224 |
| 10 | ERBB4 | 2.35884060 |
| 11 | PBK | 2.22560225 |
| 12 | NME1 | 1.95819934 |
| 13 | TAOK3 | 1.94907809 |
| 14 | MAP3K12 | 1.87729201 |
| 15 | STK24 | 1.80941439 |
| 16 | INSRR | 1.77782578 |
| 17 | STK38L | 1.77679958 |
| 18 | DAPK2 | 1.77341505 |
| 19 | PIK3CG | 1.77008696 |
| 20 | ACVR1B | 1.76228050 |
| 21 | SMG1 | 1.75566926 |
| 22 | LMTK2 | 1.69045981 |
| 23 | TTK | 1.65069490 |
| 24 | NEK6 | 1.47359253 |
| 25 | MAP3K3 | 1.36446484 |
| 26 | SGK223 | 1.34273478 |
| 27 | SGK494 | 1.34273478 |
| 28 | PDK3 | 1.30461011 |
| 29 | PDK4 | 1.30461011 |
| 30 | PTK6 | 1.28677473 |
| 31 | TRIB3 | 1.24432895 |
| 32 | BCR | 1.23881097 |
| 33 | MAPK11 | 1.23772463 |
| 34 | LATS1 | 1.18450179 |
| 35 | EPHB1 | 1.17975403 |
| 36 | EEF2K | 1.17332317 |
| 37 | MAP2K4 | 1.13610617 |
| 38 | PTK2B | 1.10982770 |
| 39 | ABL2 | 1.10468104 |
| 40 | FRK | 1.08459561 |
| 41 | PKN2 | 1.07414843 |
| 42 | MET | 1.07309161 |
| 43 | TESK1 | 1.07235334 |
| 44 | NEK1 | 1.00937318 |
| 45 | MAP3K7 | 0.96525120 |
| 46 | PDK2 | 0.91049084 |
| 47 | DYRK1B | 0.89101207 |
| 48 | TYK2 | 0.87985351 |
| 49 | GRK6 | 0.87772786 |
| 50 | MAP3K14 | 0.87192908 |
| 51 | PINK1 | 0.84840967 |
| 52 | SGK3 | 0.82523749 |
| 53 | PRKAA2 | 0.81960677 |
| 54 | TIE1 | 0.80629183 |
| 55 | GSK3A | 0.79886231 |
| 56 | PRKCI | 0.79381785 |
| 57 | JAK2 | 0.78261496 |
| 58 | SGK2 | 0.77852359 |
| 59 | MST4 | 0.75799296 |
| 60 | MAPK15 | 0.74504207 |
| 61 | RIPK1 | 0.74028631 |
| 62 | RIPK4 | 0.73833977 |
| 63 | NLK | 0.72340692 |
| 64 | MAP3K11 | 0.72087739 |
| 65 | TRPM7 | 0.71803795 |
| 66 | STK16 | 0.71630730 |
| 67 | MYLK | 0.70518990 |
| 68 | PTK2 | 0.70406885 |
| 69 | FLT3 | 0.70194443 |
| 70 | EPHA3 | 0.68297722 |
| 71 | NEK9 | 0.67241897 |
| 72 | LRRK2 | 0.66486427 |
| 73 | TGFBR2 | 0.65921197 |
| 74 | PRKCZ | 0.65169483 |
| 75 | ICK | 0.63260326 |
| 76 | FER | 0.62149842 |
| 77 | MUSK | 0.60224658 |
| 78 | FGFR2 | 0.58858708 |
| 79 | PRKACG | 0.58177676 |
| 80 | ERBB2 | 0.58002460 |
| 81 | PNCK | 0.57417386 |
| 82 | KDR | 0.56283379 |
| 83 | PRKAA1 | 0.56278888 |
| 84 | TBK1 | 0.54898823 |
| 85 | PDPK1 | 0.53892943 |
| 86 | STK38 | 0.53212112 |
| 87 | TESK2 | 0.51706629 |
| 88 | WNK1 | 0.51252540 |
| 89 | ERBB3 | 0.50965456 |
| 90 | MAPK12 | 0.49244955 |
| 91 | MAP2K3 | 0.48597536 |
| 92 | PRKCD | 0.48366085 |
| 93 | MAP2K1 | 0.48209511 |
| 94 | MAPK4 | 0.47726087 |
| 95 | TLK1 | 0.47542172 |
| 96 | MARK2 | 0.46203795 |
| 97 | PAK3 | 0.46008900 |
| 98 | CAMK2G | 0.45448353 |
| 99 | BRSK2 | 0.45028180 |
| 100 | PIK3CA | 0.44423222 |
| 101 | JAK1 | 0.43421379 |
| 102 | EPHA2 | 0.42929721 |
| 103 | MAP2K6 | 0.42216267 |
| 104 | CDK6 | 0.41195503 |
| 105 | EPHA4 | 0.39115990 |
| 106 | MAP3K2 | 0.38976909 |
| 107 | PAK4 | 0.36730346 |
| 108 | PDK1 | 0.34802287 |
| 109 | IGF1R | 0.33249098 |
| 110 | CAMKK1 | 0.33237807 |
| 111 | PRKG2 | 0.32574040 |
| 112 | CSK | 0.31825332 |
| 113 | AKT2 | 0.30444730 |
| 114 | BMX | 0.28488802 |
| 115 | PRKCQ | 0.28194664 |
| 116 | PRKCA | 0.27567862 |
| 117 | CAMK1D | 0.27467859 |
| 118 | NME2 | 0.27331164 |
| 119 | MATK | 0.27155099 |
| 120 | MAP3K10 | 0.25110026 |
| 121 | STK10 | 0.23995227 |
| 122 | MTOR | 0.23792371 |
| 123 | SRC | 0.23401478 |
| 124 | ROCK1 | 0.23369030 |
| 125 | IRAK3 | 0.23011436 |
| 126 | ROCK2 | 0.21797472 |
| 127 | PRKCE | 0.21226482 |
| 128 | EGFR | 0.20362584 |
| 129 | GRK1 | 0.20312114 |
| 130 | SGK1 | 0.19926962 |
| 131 | MAPKAPK3 | 0.19627738 |
| 132 | CDC42BPA | 0.19554460 |
| 133 | CAMK4 | 0.19001352 |
| 134 | ABL1 | 0.18882987 |
| 135 | PRKG1 | 0.18154618 |
| 136 | FGFR3 | 0.17673612 |
| 137 | PRKCG | 0.17535530 |
| 138 | MAP2K2 | 0.17460050 |
| 139 | CDK19 | 0.17150785 |
| 140 | PRKACA | 0.17088286 |
| 141 | IKBKE | 0.15632066 |
| 142 | FYN | 0.15441768 |
| 143 | MAP3K4 | 0.14182438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.86738255 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.60628884 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01179389 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85004778 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80706654 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79476798 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68080605 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67276060 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.58875803 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49922090 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48700135 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.45177527 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33543862 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32783318 |
| 15 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31269425 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.24080719 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10448576 |
| 18 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01723742 |
| 19 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00485233 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93884703 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92389422 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86625736 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84492633 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78100875 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76981579 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74993659 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71784442 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66230140 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65327373 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.63100035 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60529452 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59899489 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58912595 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54825273 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54335986 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53097389 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50718864 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45137924 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32935215 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32571481 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32529814 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30741376 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29426371 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27621895 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23976500 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23830656 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19893248 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16167926 |
| 49 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.15956343 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12724611 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10627503 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07255137 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06890359 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.06846071 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04517040 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01901132 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96938779 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94924006 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.91119810 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79152919 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78854554 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78068733 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77966486 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77018100 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76368667 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71905430 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69506156 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64885249 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64332300 |
| 70 | Tight junction_Homo sapiens_hsa04530 | 0.53473699 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49021806 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46147491 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45467502 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43169426 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40082949 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31253520 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28435195 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28127063 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.20248735 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15168417 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15099376 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.15082743 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14835544 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14220359 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14153612 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12872513 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11440490 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11330164 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09340961 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06785500 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.06645376 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05737896 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05689814 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05221076 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.04281367 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.03825826 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03727711 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.03678456 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00684881 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2001314 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1874267 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1814435 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1474609 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1386691 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1317381 |
| 106 | Lysosome_Homo sapiens_hsa04142 | -0.0954547 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0864499 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | -0.0828991 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0530790 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | -0.0469018 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0403741 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0348805 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0340563 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0315886 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0285832 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0102845 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | -0.0096636 |

